Dr. Jonathan L. Gleason is a renowned thought leader and healthcare executive. He has served in executive roles at several of America’s most notable clinically integrated health systems – Carilion Clinic, Jefferson Health, and Prisma Health. Dr. Gleason currently serves as executive vice president, Chief Clinical Officer for Prisma Health with broad responsibilities for the clinical and academic mission of the $5bn, 18-hospital clinical integrated health system. His work to build clinical operating systems that are elite partners to people has achieved remarkable results inside of traditional health systems as well as in the business community. Dr. Gleason’s work has been recognized by multiple national awards for innovation in care delivery and safety, and his insights on these topic are in high demand in publications such as the New England Journal, the World Economic Forum and the Wall Street Journal. Dr. Gleason is also a researcher and advocate for people with disabilities and his landmark publication in the New England Journal of Medicine Catalyst about the impact of COVID-19 on individuals with intellectual disabilities resulted in global changes to vaccine prioritization. Dr. Gleason serves on advisory committees for Special Olympics International, and he serves on the board of Special Olympics Pennsylvania.